PCR approach for detection of Fragile X syndrome and Huntington disease based on modified DNA: Limits and utility

Genetic Testing

Volumn 11, Issue 2, 2007, Pages 153-159

  Rosales Reynoso, Monica Alejandra ^a   Vilatela, Elisa Alonso ^b   Ojeda, Rosario Macias ^b   Arce Rivas, Aura ^c   Sandoval, Lucila ^a   Troyo Sanromán, Rogelio ^d   Barros Núñez, Patricio ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FRAGILE X SYNDROME; GENE AMPLIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TRINUCLEOTIDE REPEAT;

DNA; FRAGILE X SYNDROME; HUMANS; HUNTINGTON DISEASE; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRINUCLEOTIDE REPEATS;

EID: 34447269154     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2006.0508     Document Type: Article

References (47)

1. Alonso ME, Yescas P, Cisneros B, Martínez C, Silva G, Ochoa A, Montañez C (1997) Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population. Clin Genet 51:225-230.
2. Bell MV, Hirts MC, Nakahori Y, Mackinnon RN, Roche A, Flint TJ, Jacobs PA, Tommerup N, Tranebjaerg L, Froster-Iskenius U, Kerr B, Turner G, Lindenbaum RH, Winter R, Pembrey M, Thibodeau S, Davies KE (1991) Physical Mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome. Cell 64:861-866.
3. Brown WT, Houck GEJ, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. J Am Med Assn 270:1569-1575.
4. Castellvi-Bell S, Matilla T, Banchs MI, Kruyer H, corral J, Estivil X (1994) Chemiluminiscent detection of blotted PCR products (CB-PCR) of two CAG dynamic mutations (Huntington's disease and spinocerebellar ataxia type 1). J Med Genet 31:654-655.
5. Chong SS, Eichler EE, Nelson DL, Hughes MR (1994) Robust amplification and ethidium visible detection of the fragile X syndrome CGG repeats using Pfu polymerase. Am J Med Genet 51:522-526.
6. Condorelli DF, Mulana G, Dell'Albani P, Roccazzello A, Insirello E, Pavone L, Mollica F (1996) Routine clinical application of the FRAXA Pfu PCR assay: limits and utility. Clin Genet 50:366-371.
7. Das S, Kubota T, Song M, Daniel R, Berry-Kravis EM, Prior TW, Popovich B, Rosser L, Arinami T, Ledbetter DH (1997) Methylation analysis of the fragile X syndrome by PCR. Genet Test 1:151-155.
8. El-Aleem AA, Böhm I, Temtamy S, El-Awady M, Awadalla M, Schmidtke J, Stuhrmann M (1995) Direct molecular analysis of the fragile X syndrome in a sample of Egyptian and German patients using non-radiactive PCR and Southern blot followed by chemiluminiscent detection. Clin Genet 96:577-584.
9. Erster SH, Brown WT, Goonewardena P, Roccazzello AM, Insirello E, Pavone L, Mollica F (1992) Polymerase chain reaction analysis of Fragile X mutations. Hum Genet 90:55-61.
10. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RGJ, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991) Variations of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
11. Gusella JF, Wexlex NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Otina K, Wallace MR, Sakaguchi AY (1983) A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306:234-238.
12. Haddad LA, Mingroni-Netto RC, Viana-Morgante AM, Pena SD (1996) A PCR based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet 97:808-812.
13. Harper PS (1991) The natural history of Huntington's disease. In: Harper PS (ed) Huntington's disease. W.B. Saunders, London pp 127-139.
14. Hayden MR, Kremer B (2001) Huntington disease. In: Scriver CR, Beaudet AL, Sly Ws, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5677-5701.
15. Hecimovic S, Barisic I, Müller A, Petkovic I, Baric I, Ligutic I, Pavelic K (1997) Expand long PCR for fragile X mutation detection. Clin Genet 52:147-154.
16. Hecimovic S, Vlasic J, Barisic I, Markovic D, Culic V, Pavelic K (2001) A simple and rapid analysis of triplet repeat diseases by Expand Long PCR. Clin Chem Lab 39:1259-1262.
17. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeats that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
18. Knight SJL, Flannery AV, Hirts MC, Campbell L, Christodoulou Z, Phepls SR, Pointon J, Middleton-Price HR, Barnicoat A, Pembrey ME, Holland J, Oostra BA, Bobrow M, Davies KE (1993) Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-134.
19. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CGG)n. Science 252:1711-1714.
20. Larsen LA, Gronskov K, Norgaard-Pedersen B, Bromdum-Nielsen K, Hasholt L, Vuust J (1997) High-throuhput analysis of fragile X (CGG)n alleles in the normal and premutated range by PCR amplification and automated capillary electrophoresis. Hum Genet 100:564-568.
21. Latimer LJ, Lee JS (1991) Ethidium bromide does not fluoresce when intercalated adjacent to 7-Deazaguanine in duplex DNA. J Biol Chem 266:13849-13851.
22. Levinson G, Maddalena A, Palmer F, Harton GL, Bick DP, Howard-Peebles PN, Black SH, Schulman JD (1994) Improved sizing of Fragile X CGG repeats by nested polymerase Chain reaction. Am J Med Genet 51:527-534.
23. Margolis RL, Ross CA (2003) Diagnosis of Huntington disease. Clin Chem 10:1726-1732.
24. Martin JB, Gusella JF (1986) Huntington's disease: pathogenesis and management. N Engl J Med 315:1267-1276.
25. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
26. Muglia M, Ieone O, Annesi G, Gabriele AL, Imbrogno E, Grandinetti C, Conforti FL, Naso F, Brancati C (1996) Nonisotopic method for acurate detection of (CAG)n repeats causing Huntington disease. Clin Chem 42:1601-1603.
27. Nance MA, Mathias-Hagen V, Breningstall G, Wick MJ, McGlennan RC (1999) Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease. Neurology 52:292-394.
28. Oberle I, Rosseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
29. Oostra BA, Halley DJJ (1995) Complex behaviour of simple repeats: The fragile X syndrome. Pediat Res 38:629-637.
30. Panagopoulos I, Lassen C, Kristoffersson U, Aman P (1999a) A methylation PCR approach for detection of fragile X syndrome. Hum Mulat 14:71-79.
31. Panagopoulos I, Lassen C, Kristoffersson U, Aman P (1999b) A novel PCR based approach for the detection of the Huntington disease associated trinucleotide repeat expansion. Hum Mutat 14:232-236.
32. Pergolizzi RG, Erster SH, Goonewardena P, Brown WT (1992) Detection of full fragile X mutation. Lancet 339:271-272.
33. Riess O, Noerremoelle A, Soerensen SA, Epplen JT (1993) Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease. Hum Mol Genet 2:637.
34. Rousseau F, Heitz D, Biancalana V, Kretz C, Boué J, Tommerup N, Van der Hagen C, Delozier-Blanchet C, Croquette MF, GilgenKrantz S, Jalbert P, Voelckel MA, Oberlé I, Mandel JL (1991) Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325:1673-1681.
35. Rousseau F, Heitz D, Biancalana V, Oberlé I, Mandel JL (1992) On some technical aspects of direct DNA diagnosis of the fragile X syndrome. Am J Med Genet 43:197-207.
36. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schwartz C, Mandel JL (1994) A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB 12.3: the first 2,253 cases. Am J Hum Genet 55:225-237.
37. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400.
38. Tejada I, Mornet E, Biancalana V (1992) Direct DNA analysis of fragile X syndrome in Spanish pedigrees. Am J Med Genet 43:282-290.
39. Tóth T, Findlay I, Nagy B, Papp Z (1997) Accurate Sizing of (CAG)n repeats causing Huntington Disease by Fluorescent PCR. Clin Chem 43:2422-2423.
40. Valdes JM, Tagle DA, Elmer LW, Collins FS (1993) A simple non radioactive method for diagnosis of Huntington's disease. Hum Mol Genet 2:633-634.
41. Verkerk AJMH, Pierctti M, Sutcliffe JS, Fu YH, Kuhl DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, Van Ommen GJB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in the fragile X syndrome. Cell 65:905-914.
42. Wang Q, Green E, Bobrow M, Mathew CG (1995) A rapid, nonradioactive screening test for fragile X mutations at the FRAXA and FRAXE loci. J Med Genet 32:170-173.
43. Warner JP, Barron LB, Brock DJP (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that in unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 7:235-239.
44. Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ (1996) A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 12:1022-1026.
45. Warren ST, Sherman SL (2001) The Fragile X syndrome. In: Scriver CR, Beaudet AL, Sly Ws, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1257-1289.
46. Weinhausel A, Hass OA (2001) Evaluation of the fragile X (FRAXA) syndrome with methylation sensitive PCR. Hum Genet 108:450-458.
47. Zhou Y, Law HY, Boehn CD, Yoon CS, Cutting GR, Ng SL, Chong SS (2004) Robust Fragile X (CGG)n genotype clasification using a methylation specific triple PCR assay. J Med Genet 41:1-8.